Skip to main content
Caplight Logo









NeogenTC

NeogenTC

Private
SeoulHealthcare & Life Scienceshttp://neogentc.com/

Last Round

Series B

Feb 1, 2024

Total Funding Raised

$19.52M

Company Overview

NeogenTC is a biotechnology company that develops personalized anti-cancer immune T-cell therapies based on a novel antigen discovery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

adoptive cell therapytumor-infiltrating lymphocytesTIL therapycell therapyTCR-TTCR-engineered T-cell therapypersonalized immunotherapysolid tumor treatmentcancer immunotherapyneoantigengene engineering platformbiotech R&Dclinical-stage biotechprecision medicinenext-gen cancer drugs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeogenTC Comparables

Compare NeogenTC with similar companies based on industry and business-model similarity.

NeogenTC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Juncell Therapeutics Co., Ltd.
87%
Grit Biotherapeutics
86%
Obsidian Therapeutics
83%

NeogenTC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 1, 2024
Series AApr 6, 2021
SeedDec 1, 2020

NeogenTC Investors

Notable investors and investment history

NeogenTC investors
InvestorRounds
Seoul Investment PartnersSeries A
DSC InvestmentSeries A
Bluepoint PartnersSeed
TS InvestmentSeries A
LogInvestmentSeries A
Tcha Partners Asset ManagementSeries A
QUAD VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 79% to 3,000.

  • Jun 1, 2025

    Monthly visitors increased 42% MoM.

NeogenTC Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeogenTC Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeogenTC's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2020
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?